Ci4CC’s 23rd Cancer Center Summit to focus on accelerating oncology innovation through AI

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

We are at a transformational period in oncology; the overall mortality from cancer is gradually declining in the United States. 

This is attributable to approaches towards prevention, earlier detection, and better treatment options. Precision approaches have improved outcomes even for several malignancies that present at an advanced stage of the disease. 

The ability to incorporate AI across all aspects of cancer care and research will accelerate the pace of innovation. 

We will explore how AI-powered tools enable prevention, cancer screening, diagnosis, therapy and clinical trials. Real-time analysis of complex genomic, multi-omics, and clinical data are driving personalized treatment strategies such as biomarker-based therapies and adaptive clinical trial designs. 

Additionally, we will showcase AI’s role in improving diagnostic accuracy through enhanced imaging analysis, automated pathology reviews, and predictive models for patient risk stratification. 

By integrating AI within translational research and precision oncology workflows, we aim to accelerate discoveries, enhance diagnostics, streamline clinical decision-making, and ultimately improve survival outcomes for patients with cancer. The potential of AI to accelerate patient matching and accrual to clinical trials will be another key feature of the meeting.

This summit provides actionable insights into the next frontier of AI-enabled precision medicine, emphasizing its transformative potential in improving cancer-related mortality worldwide. The sessions will focus on cutting-edge advances in leveraging AI-driven approaches to enhance cancer screening, molecular profiling, treatment decision-making, and patient outcome prediction. 

Welcome video from Suresh Ramalingam

About the 23rd Cancer Center Summit

This spring marks the 23rd Cancer Center Informatics Society Summit, bringing together leaders from NCI-Designated and Community Cancer Centers in San Diego, May 16–18. 

We are entering a pivotal era in oncology, where the convergence of artificial intelligence and cancer research is redefining what’s possible. As cancer mortality rates continue to decline, AI is driving the next wave of innovation by enhancing prevention, early detection, diagnosis, and treatment.

Suresh S. Ramalingam

The focus: how AI-powered tools are revolutionizing every aspect of cancer care—from real-time multi-omics integration and biomarker-guided therapies to adaptive clinical trials and predictive modeling.

Join your colleagues from leading academic medical centers, cancer institutions, biotech and life science companies, and clinical research networks including cooperative groups to explore how AI is advancing diagnostic precision, accelerating clinical trial enrollment, and powering personalized treatment strategies. Organized by Cancer Center leaders in oncology, informatics, and data science, this Spring 2025 summit will showcase how AI is unlocking the full potential of translational research and precision medicine to improve cancer outcomes for patients worldwide.

Summit themes include:

  • AI in Early Detection & Prevention
  • Clinical Decision Support & Biomarker-Based Therapy
  • Real-World Evidence & Adaptive Trial Design
  • AI in Imaging, Pathology & Risk Prediction
  • AI Agents in Clinical Workflow
  • Next-Gen Shared Resources for Oncology Research
  • Inside the Directors Office – A Fireside Chat on Toop Strategic Priorities
  • From Strategy to Practice: Chief Officers Discuss Real World AI in Oncology
  • Hands-on Hackathon leveraging ChatGPT

Access all conference details—including registration, hotel information, the latest agenda, and sponsorship opportunities. 

In keeping with the focus of the conference, Ci4CC is proud to launch its latest national initiative—the Health Universe AI Collaborative—at this year’s Summit. This groundbreaking effort brings together leaders from cancer centers, life sciences, and technology to co-develop modular, AI-driven tools and workflows aimed at transforming cancer research, clinical trials, and precision care. The initiative will kick off with a real-world clinical data Hackathon at the conference, powered by ChatGPT and Health Universe, and a national virtual hackathon, showcasing practical applications of AI in oncology.

Advancements in cancer research and clinical care are never achieved in isolation. That is why fostering collaborative networks is fundamental to our Initiatives Program and central to the Societies Mission. 


Stay informed about the conference and sign-up for ongoing webinar and lecture series in cancer informatics and technology downloads through www.ci4cc.org/events.

Suresh S. Ramalingam, MD
Executive director, Winship Cancer Institute of Emory University; Associate vice president for cancer, Woodruff Health Sciences Center; Roberto C. Goizueta Distinguished Chair for Cancer Research; Professor, Department of Hematology and Medical Oncology, Emory University School of Medicine; Editor-in-chief, Cancer; Chair, 23rd Cancer Center Summit
Adam Marcus, PhD
Deputy director, Winship Cancer Institute of Emory University; Winship 5K Research Professor in the Department of Hematology and Medical Oncology, Emory University School of Medicine; Co-chair, 23rd Cancer Center Summit
Table of Contents

YOU MAY BE INTERESTED IN

The American Association for Cancer Research-Novocure Career Development Award for Cancer Research represents a joint effort to promote and support early-career investigators who are conducting innovative research focused on Tumor Treating Fields (TTFields; intermediate frequency, low intensity, alternating electric fields that disrupt cell division in cancer cells) as well as to encourage early-career investigators to enter the TTFields research field. 
Suresh S. Ramalingam, MD
Executive director, Winship Cancer Institute of Emory University; Associate vice president for cancer, Woodruff Health Sciences Center; Roberto C. Goizueta Distinguished Chair for Cancer Research; Professor, Department of Hematology and Medical Oncology, Emory University School of Medicine; Editor-in-chief, Cancer; Chair, 23rd Cancer Center Summit
Adam Marcus, PhD
Deputy director, Winship Cancer Institute of Emory University; Winship 5K Research Professor in the Department of Hematology and Medical Oncology, Emory University School of Medicine; Co-chair, 23rd Cancer Center Summit

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login